Quick Thoughts

When the US government cracked down on drug companies promoting antidepressants for children and teens

One in a series of three blog posts about Pharma’s promotion of medication for treatment of depression in young children and teens. This post concerns legal action by the US federal government in which two pharmaceutical companies pleaded guilty and had to pay large sums of money because of their promotion of misleading claims about about […]

When Simon Wessely shoved a Hans Eysenck scandal under the rug

Updated May 7, 2016 I have also now responded to Sir Simon Wessely ‘s comment on Twitter about this post. I invite a further reply from him. Soon there may be a renewed call for an investigation of misconduct by famous UK psychologist Hans Eysenck.  What happened the last time reflects on the ability of […]

As major medical journals balk, BMJ moves forward with routine data sharing.

Repeated signals that The BMJ is moving forward while editors of other key medical journals try to undermine data sharing. Institutions are stiffening their resistance to release of the promised PACE trial data from the PLOS One article. This threatens to splinter the movement for routine data sharing. But The BMJ continues to support for […]

A call for the unconditional release of the PLOS One PACE data Part 1

We are at a tipping point in the struggle for routine data-sharing. We look to journals to implement policies based on a consensus of directives from governments, requirements of funding bodies, and, now, The International Committee of Medical Journal Editors (ICMJE). But we should not confuse circulation of an ICMJE proposal with universal adoption of […]

BMJ Rapid Responses, PubMed Commons, and Blogging

Why I said no to revising my submission to BMJ Rapid Response I said that I would submit my last blog post to BMJ Rapid Responses and I did. But here is the response that I received: Dear Professor Coyne, Thank you for your rapid response (copied below). We would like to post if you […]

Our BMJ paper wins the 2013 Bill Silverman Prize from the Cochrane Collaboration

The Cochrane Collaboration has awarded my colleagues and me the honor of the 2013 Bill Silverman Prize. We are thus approved as “troublemakers.” I find this recognition quite validating and encouraging of our efforts to improve the scientific literature and dissemination of the evidence it produces to clinicians, patients, and policymakers by promoting evidence-based skepticism. […]